Discovery of a Structurally Stable Immunodominant Region in ASFV p30 C‐Terminus Using a Panel of Monoclonal Antibodies
Transboundary and Emerging Diseases · 2025-01 · 2025 (1)
DOI: 10.1155/tbed/8023572 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transboundary and Emerging Diseases, online erschienen am 28.11.2025. Verfasst von Wei Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Animal Disease Control and Prevention, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanz…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, African Swine Fever Virus, African Swine Fever, Immunodominant Epitopes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
African swine fever (ASF) is a lethal hemorrhagic viral disease of pigs with devastating global socioeconomic impacts. Due to the absence of a safe and effective vaccine, early surveillance and precise diagnostics are critical for ASF prevention and control. The ASF virus (ASFV) p30 protein, one of the most immunogenic early‐expressed antigens during infection, is a prime target for diagnostic assays and subunit vaccines. Its comprehensive antigenic characterization remains crucial for rational vaccine design. In this study, we generated a panel of 20 monoclonal antibodies (MAbs) against the ASFV p30 protein, classifying them into 11 groups based on epitope specificity. MAbs from six groups (subgroups I‐1, I‐2, and II‐1, as well as groups III, IV, and V, collectively comprising 15 MAbs) recognized six distinct epitopes within the C‐terminus of p30 (137–194 aa), while MAb 16‐5E7E8 (subgroup II‐2) recognized a distinct epitope within residues 154–190. The p30 C‐terminus (137–194 aa) demonstrated structural stability under denaturing conditions (SDS–PAGE and western blot [WB]) and was identified as an immunodominant region through its reactivity with ASFV‐positive sera. Notably, MAbs targeting this immunodominant region exhibited modest neutralizing activity, whereas those binding to other regions showed no neutralizing activity. Furthermore, MAb Q4‐1F10B7 (group VI) recognized a linear epitope “ 116 TSSFETLFEQ 125 ,” MAbs Q1‐1G4B2 (group VIII) and Q8‐4F9F3 (group IX) recognized conformation‐dependent epitopes, and MAb 5‐1C8B6 (group VII) likely recognized an aberrant or non‐native form of the p30 protein. These results expand the epitope landscape of p30 protein and lay a foundation for ASF diagnosis and vaccine research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Animal Disease Control and Prevention, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China.
- Gansu Province Research Center for Basic Disciplines of Pathogen Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China.
ORCID-Profile: Wei Liu, Shandian Gao, Huichen Guo, Junjun Shao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, W., Gao, S., Su, J., Sui, J., Zhou, T., Yang, J., Lu, H., Guo, H., Shao, J., & Chang, H. (2025). Discovery of a Structurally Stable Immunodominant Region in ASFV p30 C‐Terminus Using a Panel of Monoclonal Antibodies. Transboundary and Emerging Diseases, 2025(1). https://doi.org/10.1155/tbed/8023572
Vancouver
Liu W, Gao S, Su J, Sui J, Zhou T, Yang J, et al. Discovery of a Structurally Stable Immunodominant Region in ASFV p30 C‐Terminus Using a Panel of Monoclonal Antibodies. Transboundary and Emerging Diseases. 2025;2025(1). doi:10.1155/tbed/8023572
BibTeX
@article{Liu2025,
author = {Liu, Wei and Gao, Shandian and Su, Jiaoyan and Sui, Jinshu and Zhou, Tong and Yang, Jian and Lu, Haiyan and Guo, Huichen and Shao, Junjun and Chang, Huiyun},
title = {Discovery of a Structurally Stable Immunodominant Region in ASFV p30 C‐Terminus Using a Panel of Monoclonal Antibodies},
journal = {Transboundary and Emerging Diseases},
year = {2025},
volume = {2025},
number = {1},
doi = {10.1155/tbed/8023572}
}
EUVIMED